世界のベタヒスチン市場予測 2021年-2026年

【英語タイトル】Global Betahistine Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY9439)・商品コード:LPI21MY9439
・発行会社(調査会社):LP Information
・発行日:2021年5月(※2024年版があります。お問い合わせください)
・ページ数:133
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「ベタヒスチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、8mg、25mg、その他など、用途別には、脳血栓症、脳塞栓症、その他などにセグメント区分してまとめました。ベタヒスチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ベタヒスチンの世界市場概要(サマリー)
・ベタヒスチンの企業別販売量・売上
・ベタヒスチンの企業別市場シェア
・ベタヒスチンの世界市場規模 2016年-2021年:種類別(8mg、25mg、その他)
・ベタヒスチンの世界市場規模 2016年-2021年:用途別(脳血栓症、脳塞栓症、その他)
・ベタヒスチンの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・ベタヒスチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ベタヒスチンのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ベタヒスチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ベタヒスチン市場の成長要因・課題・動向
・ベタヒスチンの世界市場予測 2021年-2026年
・ベタヒスチンの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・ベタヒスチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ベタヒスチンのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ベタヒスチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ベタヒスチンの世界市場予測:種類別(8mg、25mg、その他)
・ベタヒスチンの世界市場予測:用途別(脳血栓症、脳塞栓症、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Betahistine will have significant change from previous year. By the most conservative estimates of global Betahistine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Betahistine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Betahistine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
8mg
25mg
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cerebral Thrombosis
Cerebral Embolism
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
TOWA PHARMACEUTICAL CO., LTD
Nichi-Iko Pharmaceutical
Takeda Pharmaceutical Company Limited
EA Pharma Co., Ltd.
Disphar International B.V.
HENNIG ARZNEIMITTEL GmbH & Co. KG
DOC Generici
Ciclum Farma Unipessoal
Mylan
Orion Corporation

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Betahistine Consumption 2016-2026
2.1.2 Betahistine Consumption CAGR by Region
2.2 Betahistine Segment by Type
2.2.1 8mg
2.2.2 25mg
2.2.3 Others
2.3 Betahistine Sales by Type
2.3.1 Global Betahistine Sales Market Share by Type (2016-2021)
2.3.2 Global Betahistine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Betahistine Sale Price by Type (2016-2021)
2.4 Betahistine Segment by Application
2.4.1 Cerebral Thrombosis
2.4.2 Cerebral Embolism
2.4.3 Others
2.5 Betahistine Sales by Application
2.5.1 Global Betahistine Sale Market Share by Application (2016-2021)
2.5.2 Global Betahistine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Betahistine Sale Price by Application (2016-2021)

3 Global Betahistine by Company
3.1 Global Betahistine Sales Market Share by Company
3.1.1 Global Betahistine Sales by Company (2019-2021)
3.1.2 Global Betahistine Sales Market Share by Company (2019-2021)
3.2 Global Betahistine Revenue Market Share by Company
3.2.1 Global Betahistine Revenue by Company (2019-2021)
3.2.2 Global Betahistine Revenue Market Share by Company (2019-2021)
3.3 Global Betahistine Sale Price by Company
3.4 Global Manufacturers Betahistine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Betahistine Product Location Distribution
3.4.2 Players Betahistine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Betahistine by Region
4.1 Global Betahistine by Region
4.1.1 Global Betahistine Sales by Region
4.1.2 Global Betahistine Revenue by Region
4.2 Americas Betahistine Sales Growth
4.3 APAC Betahistine Sales Growth
4.4 Europe Betahistine Sales Growth
4.5 Middle East & Africa Betahistine Sales Growth

5 Americas
5.1 Americas Betahistine Sales by Country
5.1.1 Americas Betahistine Sales by Country (2016-2021)
5.1.2 Americas Betahistine Revenue by Country (2016-2021)
5.2 Americas Betahistine Sales by Type
5.3 Americas Betahistine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Betahistine Sales by Region
6.1.1 APAC Betahistine Sales by Region (2016-2021)
6.1.2 APAC Betahistine Revenue by Region (2016-2021)
6.2 APAC Betahistine Sales by Type
6.3 APAC Betahistine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Betahistine by Country
7.1.1 Europe Betahistine Sales by Country (2016-2021)
7.1.2 Europe Betahistine Revenue by Country (2016-2021)
7.2 Europe Betahistine Sales by Type
7.3 Europe Betahistine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Betahistine by Country
8.1.1 Middle East & Africa Betahistine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Betahistine Revenue by Country (2016-2021)
8.2 Middle East & Africa Betahistine Sales by Type
8.3 Middle East & Africa Betahistine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Betahistine Distributors
10.3 Betahistine Customer

11 Global Betahistine Market Forecast
11.1 Global Betahistine Forecast by Region
11.1.1 Global Betahistine Forecast by Regions (2021-2026)
11.2.2 Global Betahistine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Betahistine Forecast by Type
11.7 Global Betahistine Forecast by Application

12 Key Players Analysis
12.1 TOWA PHARMACEUTICAL CO., LTD
12.1.1 TOWA PHARMACEUTICAL CO., LTD TOWA PHARMACEUTICAL CO., LTD Company Information
12.1.2 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Offered
12.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 TOWA PHARMACEUTICAL CO., LTD Main Business Overview
12.1.5 TOWA PHARMACEUTICAL CO., LTD Latest Developments
12.2 Nichi-Iko Pharmaceutical
12.2.1 Nichi-Iko Pharmaceutical Company Information
12.2.2 Nichi-Iko Pharmaceutical Betahistine Product Offered
12.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Nichi-Iko Pharmaceutical Main Business Overview
12.2.5 Nichi-Iko Pharmaceutical Latest Developments
12.3 Takeda Pharmaceutical Company Limited
12.3.1 Takeda Pharmaceutical Company Limited Company Information
12.3.2 Takeda Pharmaceutical Company Limited Betahistine Product Offered
12.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Takeda Pharmaceutical Company Limited Main Business Overview
12.3.5 Takeda Pharmaceutical Company Limited Latest Developments
12.4 EA Pharma Co., Ltd.
12.4.1 EA Pharma Co., Ltd. Company Information
12.4.2 EA Pharma Co., Ltd. Betahistine Product Offered
12.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 EA Pharma Co., Ltd. Main Business Overview
12.4.5 EA Pharma Co., Ltd. Latest Developments
12.5 Disphar International B.V.
12.5.1 Disphar International B.V. Company Information
12.5.2 Disphar International B.V. Betahistine Product Offered
12.5.3 Disphar International B.V. Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Disphar International B.V. Main Business Overview
12.5.5 Disphar International B.V. Latest Developments
12.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
12.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information
12.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Offered
12.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business Overview
12.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments
12.7 DOC Generici
12.7.1 DOC Generici Company Information
12.7.2 DOC Generici Betahistine Product Offered
12.7.3 DOC Generici Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 DOC Generici Main Business Overview
12.7.5 DOC Generici Latest Developments
12.8 Ciclum Farma Unipessoal
12.8.1 Ciclum Farma Unipessoal Company Information
12.8.2 Ciclum Farma Unipessoal Betahistine Product Offered
12.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Ciclum Farma Unipessoal Main Business Overview
12.8.5 Ciclum Farma Unipessoal Latest Developments
12.9 Mylan
12.9.1 Mylan Company Information
12.9.2 Mylan Betahistine Product Offered
12.9.3 Mylan Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Mylan Main Business Overview
12.9.5 Mylan Latest Developments
12.10 Orion Corporation
12.10.1 Orion Corporation Company Information
12.10.2 Orion Corporation Betahistine Product Offered
12.10.3 Orion Corporation Betahistine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Orion Corporation Main Business Overview
12.10.5 Orion Corporation Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Betahistine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 8mg
Table 3. Major Players of 25mg
Table 4. Major Players of Others
Table 5. Global Betahistine Sales by Type (2016-2021) & (K Units)
Table 6. Global Betahistine Sales Market Share by Type (2016-2021)
Table 7. Global Betahistine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Betahistine Revenue Market Share by Type (2016-2021)
Table 9. Global Betahistine Sale Price by Type (2016-2021)
Table 10. Global Betahistine Sales by Application (2016-2021) & (K Units)
Table 11. Global Betahistine Sales Market Share by Application (2016-2021)
Table 12. Global Betahistine Value by Application (2016-2021)
Table 13. Global Betahistine Revenue Market Share by Application (2016-2021)
Table 14. Global Betahistine Sale Price by Application (2016-2021)
Table 15. Global Betahistine Sales by Company (2019-2021) & (K Units)
Table 16. Global Betahistine Sales Market Share by Company (2019-2021)
Table 17. Global Betahistine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Betahistine Revenue Market Share by Company (2019-2021)
Table 19. Global Betahistine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Betahistine Producing Area Distribution and Sales Area
Table 21. Players Betahistine Products Offered
Table 22. Betahistine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Betahistine Sales by Region (2016-2021) (K Units)
Table 26. Global Betahistine Sales Market Share by Region (2016-2021)
Table 27. Global Betahistine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Betahistine Revenue Market Share by Region (2016-2021)
Table 29. Americas Betahistine Sales by Country (2016-2021) & (K Units)
Table 30. Americas Betahistine Sales Market Share by Country (2016-2021)
Table 31. Americas Betahistine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Betahistine Revenue Market Share by Country (2016-2021)
Table 33. Americas Betahistine Sales by Type (2016-2021) & (K Units)
Table 34. Americas Betahistine Sales Market Share by Type (2016-2021)
Table 35. Americas Betahistine Sales by Application (2016-2021) & (K Units)
Table 36. Americas Betahistine Sales Market Share by Application (2016-2021)
Table 37. APAC Betahistine Sales by Region (2016-2021) & (K Units)
Table 38. APAC Betahistine Sales Market Share by Region (2016-2021)
Table 39. APAC Betahistine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Betahistine Revenue Market Share by Region (2016-2021)
Table 41. APAC Betahistine Sales by Type (2016-2021) & (K Units)
Table 42. APAC Betahistine Sales Market Share by Type (2016-2021)
Table 43. APAC Betahistine Sales by Application (2016-2021) & (K Units)
Table 44. APAC Betahistine Sales Market Share by Application (2016-2021)
Table 45. Europe Betahistine Sales by Country (2016-2021) & (K Units)
Table 46. Europe Betahistine Sales Market Share by Country (2016-2021)
Table 47. Europe Betahistine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Betahistine Revenue Market Share by Country (2016-2021)
Table 49. Europe Betahistine Sales by Type (2016-2021) & (K Units)
Table 50. Europe Betahistine Sales Market Share by Type (2016-2021)
Table 51. Europe Betahistine Sales by Application (2016-2021) & (K Units)
Table 52. Europe Betahistine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Betahistine Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Betahistine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Betahistine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Betahistine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Betahistine Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Betahistine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Betahistine Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Betahistine Sales Market Share by Application (2016-2021)
Table 61. Global Betahistine Sales Forecast by Type (2021-2026) & (K Units)
Table 62. Global Betahistine Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Betahistine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Betahistine Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Betahistine Sales Forecast by Application (2021-2026) & (K Units)
Table 66. Global Betahistine Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Betahistine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Betahistine Revenue Market Share Forecast by Application (2021-2026)
Table 69. TOWA PHARMACEUTICAL CO., LTD Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 70. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Offered
Table 71. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 72. TOWA PHARMACEUTICAL CO., LTD Main Business
Table 73. TOWA PHARMACEUTICAL CO., LTD Latest Developments
Table 74. Nichi-Iko Pharmaceutical Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 75. Nichi-Iko Pharmaceutical Betahistine Product Offered
Table 76. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 77. Nichi-Iko Pharmaceutical Main Business
Table 78. Nichi-Iko Pharmaceutical Latest Developments
Table 79. Takeda Pharmaceutical Company Limited Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 80. Takeda Pharmaceutical Company Limited Betahistine Product Offered
Table 81. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 82. Takeda Pharmaceutical Company Limited Main Business
Table 83. Takeda Pharmaceutical Company Limited Latest Developments
Table 84. EA Pharma Co., Ltd. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 85. EA Pharma Co., Ltd. Betahistine Product Offered
Table 86. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 87. EA Pharma Co., Ltd. Main Business
Table 88. EA Pharma Co., Ltd. Latest Developments
Table 89. Disphar International B.V. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 90. Disphar International B.V. Betahistine Product Offered
Table 91. Disphar International B.V. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 92. Disphar International B.V. Main Business
Table 93. Disphar International B.V. Latest Developments
Table 94. HENNIG ARZNEIMITTEL GmbH & Co. KG Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 95. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Offered
Table 96. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business
Table 98. HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments
Table 99. DOC Generici Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 100. DOC Generici Betahistine Product Offered
Table 101. DOC Generici Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. DOC Generici Main Business
Table 103. DOC Generici Latest Developments
Table 104. Ciclum Farma Unipessoal Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 105. Ciclum Farma Unipessoal Betahistine Product Offered
Table 106. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. Ciclum Farma Unipessoal Main Business
Table 108. Ciclum Farma Unipessoal Latest Developments
Table 109. Mylan Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 110. Mylan Betahistine Product Offered
Table 111. Mylan Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. Mylan Main Business
Table 113. Mylan Latest Developments
Table 114. Orion Corporation Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 115. Orion Corporation Betahistine Product Offered
Table 116. Orion Corporation Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. Orion Corporation Main Business
Table 118. Orion Corporation Latest Developments
List of Figures
Figure 1. Picture of Betahistine
Figure 2. Betahistine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Betahistine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Betahistine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Betahistine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 8mg
Figure 10. Product Picture of 25mg
Figure 11. Product Picture of Others
Figure 12. Global Betahistine Sales Market Share by Type in 2020
Figure 13. Global Betahistine Revenue Market Share by Type (2016-2021)
Figure 14. Betahistine Consumed in Cerebral Thrombosis
Figure 15. Global Betahistine Market: Cerebral Thrombosis (2016-2021) & (K Units)
Figure 16. Betahistine Consumed in Cerebral Embolism
Figure 17. Global Betahistine Market: Cerebral Embolism (2016-2021) & (K Units)
Figure 18. Betahistine Consumed in Others
Figure 19. Global Betahistine Market: Others (2016-2021) & (K Units)
Figure 20. Global Betahistine Sales Market Share by Application (2016-2021)
Figure 21. Global Betahistine Revenue Market Share by Application in 2020
Figure 22. Global Betahistine Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Betahistine Revenue Market Share by Company in 2020
Figure 24. Global Betahistine Sales Market Share by Regions (2016-2021)
Figure 25. Global Betahistine Revenue Market Share by Region in 2020
Figure 26. Americas Betahistine Sales 2016-2021 (K Units)
Figure 27. Americas Betahistine Revenue 2016-2021 ($ Millions)
Figure 28. APAC Betahistine Sales 2016-2021 (K Units)
Figure 29. APAC Betahistine Revenue 2016-2021 ($ Millions)
Figure 30. Europe Betahistine Sales 2016-2021 (K Units)
Figure 31. Europe Betahistine Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Betahistine Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Betahistine Revenue 2016-2021 ($ Millions)
Figure 34. Americas Betahistine Sales Market Share by Country in 2020
Figure 35. Americas Betahistine Revenue Market Share by Country in 2020
Figure 36. Americas Betahistine Sales Market Share by Type in 2020
Figure 37. Americas Betahistine Sales Market Share by Application in 2020
Figure 38. United States Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Betahistine Sales Market Share by Region in 2020
Figure 43. APAC Betahistine Revenue Market Share by Regions in 2020
Figure 44. APAC Betahistine Sales Market Share by Type in 2020
Figure 45. APAC Betahistine Sales Market Share by Application in 2020
Figure 46. China Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Betahistine Sales Market Share by Country in 2020
Figure 53. Europe Betahistine Revenue Market Share by Country in 2020
Figure 54. Europe Betahistine Sales Market Share by Type in 2020
Figure 55. Europe Betahistine Sales Market Share by Application in 2020
Figure 56. Germany Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Betahistine Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Betahistine Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Betahistine Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Betahistine Sales Market Share by Application in 2020
Figure 65. Egypt Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Betahistine Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


★調査レポート[世界のベタヒスチン市場予測 2021年-2026年] (コード:LPI21MY9439)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のベタヒスチン市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆